Literature DB >> 15505700

Does technetium-99m diethylenetriaminepentaacetate clearance predict the clinical course of idiopathic pulmonary fibrosis?

Marco Mura1, Gelorma Belmonte, Stefano Fanti, Angela Maria Grazia Pacilli, Luca Fasano, Maurizio Zompatori, Mario Schiavina, Mario Fabbri.   

Abstract

Clearance of inhaled technetium-99m diethylenetriaminepentaacetate (99mTc-DTPA) is a potential indicator of disease activity and progression in idiopathic pulmonary fibrosis (IPF). The objective of the present study was to evaluate the prognostic value of 99mTc-DTPA scans in IPF. A total of 22 patients (18 males), aged 33 to 80 years with IPF were followed for six to 20 months (mean 13 months). At diagnosis, high resolution computed tomography (HRCT) scans showed a honeycomb pattern with bibasilar reticular opacities in all cases. At T0 (diagnosis) and T1 (follow-up), each patient had pulmonary function tests (forced vital capacity, diffusing capacity of the lung for carbon monoxide and partial arterial O2 pressure), extension of fibrosis evaluated by HRCT visual score and 99mTc-DTPA lung clearance. Results at T0 and T1 were compared, taking into account the whole population and patients with relatively fast and slow 99mTc-DTPA wash-out. 99mTc-DTPA clearance did not show any significant correlation with functional tests or HRCT score. These findings indicate that clearance of inhaled 99mTc-DTPA is not of value in following the progress of IPF.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15505700     DOI: 10.1155/2004/185705

Source DB:  PubMed          Journal:  Can Respir J        ISSN: 1198-2241            Impact factor:   2.409


  2 in total

1.  Radiographic Progression and Survival of the Different HRCT Patterns of Idiopathic Pulmonary Fibrosis.

Authors:  Marco Mura; Carlotta Rellini; Nada Taha; Francesco Paolo Sbordone; Flavia Rufi; Francesca Montesanto; Roberto Floris; Maurizio Zompatori; Gianluigi Sergiacomi
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2022-06-29       Impact factor: 1.803

2.  Clearance of technetium-99m-DTPA and HRCT findings in the evaluation of patients with Idiopathic Pulmonary Fibrosis.

Authors:  Katerina M Antoniou; Katerina Malagari; Nikolaos Tzanakis; Kostas Perisinakis; Emmanouil K Symvoulakis; Nikolaos Karkavitsas; Nikolaos M Siafakas; Demosthenes Bouros
Journal:  BMC Pulm Med       Date:  2006-02-16       Impact factor: 3.317

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.